The Trade Exhibition 2021

The National Acute Pain Symposium will once again provided unique opportunities to connect Delegates with relevant Trade Suppliers, with a range of options available for 2021. 

 

NAPS2019-0860.jpg

#NAPS

Opportunites for 2021 Now Available Live!

 

The 2021 Trade Exhibitors

download (2).png

In August 2020, Rokshaw became the first manufacturer of full spectrum EU-GMP medical cannabis in the UK. With our range of UK manufactured full spectrum oils and flower products, containing varying levels of THC & CBD content, Rokshaw is making medical cannabis more accessible and affordable than ever before. Our MHRA Approved state-of-the-art manufacturing facility, backed by the Rokshaw quality management system (QMS) and a highly trained and experienced team of staff ensures outstanding product quality without compromising on a service second-to-none. Rokshaw is part of EMMAC Life Sciences Group, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. With a unique supply and distribution network throughout Europe, EMMAC’s vision is to bring the life- enhancing potential of cannabis to those who need it. Our wealth of medical cannabis experience, combined with a network of supply and distribution partnerships throughout Europe and the UK, means that Rokshaw is uniquely positioned to meet the rapidly growing demand for cost-effective, consistent, premium quality medical cannabis products in the UK. As part of Rokshaw, we also have a GPhC registered and regulated distance selling pharmacy on-site called CBPM Access. CBPM Access takes care of all patient needs, from payment, dispense and delivery across the UK.

download (8).jpg

Mela Solutions Leading the Way in Supporting Your Specialist Team

 

Built precisely for specialised units, our products have the tools to simplify running your department by aiding the collection and analysis of your data. Whether you’re a doctor, nurse or data clerk, our systems have the ability to make your job easier.

 

Efficient and accurate pain data collection is challenging:

  • Manual processes, time restraints and high demand place additional pressure or clinical teams

  • Writing notes then inputting data duplicates effort

  • Data from manual records can’t be analysed in real time to identify trends, best practices and outcomes

  • Sharing and collaborating data with colleagues can be slow and inefficient

 

MedICUs Pain Services addresses these challenges by facilitating data entry using iPads and tablets. Its intuitive interface gives the team the opportunity to perform a more detailed assessment that will promote better patient management.

 

Acute Pain Management:

  • More meaningful interactions with post-operative patients with full care history to hand

  • Less time pressure on the clinical teams and more relaxed environment for patient

  • Complex analysis of post-surgical pain, modalities and adverse events, helps the team to evaluate and promote better pain control

Arcomedical Logo Hi Res.jpg

Arcomed ag specialises in developing and supplying premium infusion solutions globally.  Manufactured in Switzerland to the highest standards, we are committed to improving patient outcomes, offering solutions which protect the environment, whilst bringing to market a product that can be personalised for each care-area and clinical need.

 

We take clinicians feedback seriously, and this is reflected in our recent product optimisation  in the Pain Management solution. The Arcomed Chroma PCA can be used for numerous therapies including PCS (patient controlled sedation), safe PCA (patient controlled analgesia) for all patients, including weight based programming for Paediatrics. The pump can also be used for PIEB (programmed intermittent epidural bolus).

 

Arcomed ag offers a user-friendly, ergonomically designed handset, a ArcoAir breath activator and a MRI safe bulb attachment.

 

Please do visit us at our stand or contact us at Sales@Arcomed.com or 01268 544580 for more information.

20 mibe pharma UK_347_2019_UK (1).jpg

Mibe Pharma UK Ltd are a wholly owned subsidiary of Dermapharm and are currently based in South London.

Our focus is the promotion and distribution of quality branded and generic pharmaceutical products and innovative medical devices into the UK market.

Mibe Pharma UK’s current pharmaceutical product portfolio includes medicines prescribed within the therapy areas of pain management and dermatology.

We will be adding to our list of products as we look forward to significant expansion both within the UK and indeed on a global basis.

Our aim is also to ensure that patients and consumers alike have access to our product range throughout primary and secondary care sectors through a consistent and resilient supply chain.

download (3).png

Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.

 

Headquartered in Alpharetta, Georgia, Avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.

 

Avanos develops, manufactures, and markets its recognised brands in more than 90 countries.

PA_Signet-Wort-Bild_mit-Claim.jpg

PAJUNK® GmbH are a German based manufacturer that have been dedicated to Regional Anaesthesia and Pain Management for over 50 years. PAJUNK along with Professor Guenter Sprotte are the designers and the sole manufacturers of the Original Sprotte® Spinal Needle and have been for 40 years.

 

ISO/DIS 80369-6 NRFit™

 

(Connectors for Neuraxial Applications) has been accepted. In response to this directive PAJUNK® have now adopted this standard throughout the Neuraxial product range. 

 

 PAJUNK® SonoSystems utilise the market leading innovative and unique ‘Cornerstone’ reflective technology throughout the SonoPlex, SonoTap & TuohySono range of systems. Along with the unique E-Cath with Catheter over Needle technique, SonoCurl Catheters for Continuous Paravertebral Blocks. A comprehensive and complete range of products for guidance under Ultrasound.

 

PAJUNK’s commitment to Regional Anaesthesia is further enhanced with a comprehensive range of bespoke Anaesthetic Packs, Radio Frequency Needles/Electrodes, InfiltraLong Wound Catheters, Rectus Sheath Catheters and ambIT Infusion Pumps.

retrieve_image.png

Althea Company is a leading global pharmaceutical company dedicated to improving the lives of people suffering from chronic conditions through medical education of healthcare professionals and by facilitating patient access to full spectrum medical cannabis products.

 

Althea’s UK operation was founded in February 2019 to ensure pharmaceutical grade medical cannabis products are available to eligible UK patients. Althea’s ambition is to be a leading global pharma company focussed on innovation and specialist care.

Have you considered the emerging role of medical cannabis as an option in pain? 
Here at Althea, we work closely with healthcare professionals to increase  understanding about the scientific and real-world evidence guiding #medicalcannabis prescribing practices in pain conditions.

Since 2018, medical cannabis has been prescribed in the UK for patients who have received limited or no benefit from conventional therapies.

If you would like to understand more please get in touch with Manisha Oberoi or Arjun Virdi to discuss this further.

 

f you are interested in finding out more, please contact Arjun Virdi on 07543 494328 or use the contact button to email.

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine. To achieve this, we pursue an integrated access strategy that focuses our work on improving access to medicines, access to medical information and access to medical capacity building. This includes efforts to provide and support appropriate training for healthcare professionals. In 2020, our products reached approximately 500m patients worldwide1.

References 1. Sandoz. https://www.sandoz.com/about-us/who-we-are/our-purpose-and-ambition

Improving patient outcomes and reducing cost of care.

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes, reduce the cost of care, and take non-invasive monitoring to new sites and applications.

Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry was first introduced in 1995 and since then has continued to innovate in pulse oximetry technologies. Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, Patient SafetyNet, Replica™, Halo ION™, UniView®, UniView:60™, and most recently, Masimo SafetyNet™.

Founded in 1921 Sintetica has in its legacy specialist anaesthetics and analgesics that are manufactured in Switzerland by people with a real passion and ethical responsibility for what they do. Manufacturing to the strict standards of Swiss, European, US and international agencies, continuously supplying its customers on time, every time, across the globe, Sintetica is dedicated to being the world leader in sustainable anaesthesia.

 

Sintetica sees sustainability and the environment as its essential fabric, only using energy from 100% renewable sources in the manufacture of its medicines. By only using renewable energy Sintetica is protecting the environment for future generations.

Event Cancellation Policy

 

If you should have to cancel your stand, notification in writing should be sent to

naps@cloud9em.co.uk

  • A refund of 85% will be given for cancellations received 90 days prior to the start of the event

  • A refund of 50% will be given for cancellations received between 89 days prior to 61 days to the start of the event 

  • A refund of 25% will be given for cancellations received between 60 days prior to 31 days to the start of the event 

  • No refund will be issued for cancellations received within 30 days of the event, nor failure to attend

 

Force Majeure

Cloud 9 Event Management Ltd, who operate the National Acute Pain Symposium, shall not be liable to refund of fees or for any other penalty should the event be cancelled due to war, fire, strike lock-out, industrial action, tempest, accident, civil disturbance or any other cause whatsoever beyond their control.